71 related articles for article (PubMed ID: 3873623)
1. Distribution of subpopulations of T lymphocytes in Hodgkin's disease.
Gulwani BN; Advani SH; Gangal SG
Neoplasma; 1985; 32(2):239-46. PubMed ID: 3873623
[TBL] [Abstract][Full Text] [Related]
2. Subpopulations of human T lymphocytes in patients with Hodgkin's disease before and after treatment.
Karande AA; Gulwani B; Advani SH; Gangal SG
Neoplasma; 1982; 29(2):149-59. PubMed ID: 6981068
[TBL] [Abstract][Full Text] [Related]
3. Functional activities of enriched Fc receptor bearing T lymphocytes in Hodgkin's disease.
Gulwani BN; Advani SH; Gangal SG
Oncology; 1986; 43(3):159-64. PubMed ID: 2939383
[TBL] [Abstract][Full Text] [Related]
4. T lymphocyte subpopulations defined by monoclonal antibodies in synovial fluid of patients with rheumatic disease.
Nilsson E; Biberfeld G
J Clin Lab Immunol; 1982 Nov; 9(2):93-7. PubMed ID: 6984082
[TBL] [Abstract][Full Text] [Related]
5. Studies of cell subpopulations mediating mitogen hyporesponsiveness in patients with Hodgkin's disease.
Sibbitt WL; Bankhurst AD; Williams RC
J Clin Invest; 1978 Jan; 61(1):55-63. PubMed ID: 304068
[TBL] [Abstract][Full Text] [Related]
6. Lymphocyte compartments in human spleen. An immunohistologic study in normal spleens and uninvolved spleens in Hodgkin's disease.
Timens W; Poppema S
Am J Pathol; 1985 Sep; 120(3):443-54. PubMed ID: 3898859
[TBL] [Abstract][Full Text] [Related]
7. Surface markers and cytotoxic activity of blood natural killer cells studied at the single cell level in Hodgkin's disease.
Jezewska E; Björkholm M; Giscombe R; Holm G; Tullgren O
Clin Exp Immunol; 1985 Jul; 61(1):96-102. PubMed ID: 4042422
[TBL] [Abstract][Full Text] [Related]
8. Immunologic parameters in childhood Hodgkin's disease II. T and B lymphocytes in the peripheral blood of normal children and in the spleen and peripheral blood of children with Hodgkin's disease.
de Sousa M; Tan CT; Siegal FP; Filippa DA; Tan R; Good RA
Pediatr Res; 1978 Feb; 12(2):143-7. PubMed ID: 306089
[TBL] [Abstract][Full Text] [Related]
9. Clonal analysis of T lymphocytes in spleens from patients with Hodgkin's disease. Frequent occurrence of unusual T4-positive cells which co-express cytolytic activity and production of interleukin-2.
Romagnani S; Maggi E; Parronchi P; Macchia D; Del Prete GF; Rossi-Ferrini PL; Ricci M; Moretta L
Int J Cancer; 1986 Mar; 37(3):343-9. PubMed ID: 3081452
[TBL] [Abstract][Full Text] [Related]
10. Impaired lymphocyte transformation in Hodgkin's disease. Evidence for depletion of circulating t-lymphocytes.
Matchett KM; Huang AT; Kremer WB
J Clin Invest; 1973 Aug; 52(8):1908-17. PubMed ID: 4541673
[TBL] [Abstract][Full Text] [Related]
11. Identification of three FcR-positive T cell subsets (T gamma, T mu and T gamma mu) in the cerebrospinal fluid of multiple sclerosis patients.
Merrill JE; Biberfeld G; Landin S; Sidén A; Norrby E
Clin Exp Immunol; 1980 Nov; 42(2):345-54. PubMed ID: 6970641
[TBL] [Abstract][Full Text] [Related]
12. Characterization of immunoregulatory T cells and lymphocytophilic antibodies in ulcerative colitis: analysis with monoclonal antibodies.
Aiso S; Watanabe M; Hibi T; Yoshida T; Tsuchiya M; Tsuru S
J Clin Lab Immunol; 1982 Nov; 9(2):109-12. PubMed ID: 6984077
[TBL] [Abstract][Full Text] [Related]
13. Natural killer activity in spleens and lymph nodes from patients with Hodgkin's disease.
Ruco LP; Procopio A; Uccini S; Marcorelli E; Baroni CD
Cancer Res; 1982 May; 42(5):2063-8. PubMed ID: 6175405
[TBL] [Abstract][Full Text] [Related]
14. Splenic T and B lymphocytes and their mitogenic response in untreated Hodgkin's disease.
Han T; Minowada J; Subramanian V; Barcos M; Kim U
Cancer; 1980 Feb; 45(4):767-74. PubMed ID: 6965606
[TBL] [Abstract][Full Text] [Related]
15. The T and B lymphocyte content of lymph nodes and spleen in Hodgkin's disease.
Stathopoulos G; Papamichail M; Peckham MJ; Davies AJ; Holborow EJ
Br J Exp Pathol; 1977 Dec; 58(6):712-6. PubMed ID: 305255
[TBL] [Abstract][Full Text] [Related]
16. [Infiltrating lymphocytes in esophageal carcinoma--II. Subsets of T lymphocytes].
Wang HF
Zhonghua Zhong Liu Za Zhi; 1986 Jan; 8(1):20-2. PubMed ID: 2942379
[TBL] [Abstract][Full Text] [Related]
17. Immunological markers of peripheral blood and lymph node lymphocytes in Hodgkin's disease.
González M; Hernández F; San Miguel JF; Moraleda JM; Caballero MD; López Borrasca A
Neoplasma; 1985; 32(2):191-8. PubMed ID: 4000308
[TBL] [Abstract][Full Text] [Related]
18. [Immunoregulatory subpopulations of T-lymphocytes and their distribution in the peripheral blood, lymph nodes and spleen of patients with lymphogranulomatosis].
Kharabadze MV; Tabagari DZ
Ter Arkh; 1989; 61(7):30-2. PubMed ID: 2686065
[TBL] [Abstract][Full Text] [Related]
19. Systemic administration of human leukocyte interferon to melanoma patients. III. Increased helper:suppressor cell ratios in melanoma patients during interferon treatment.
Karavodin LM; Golub SH
Nat Immun Cell Growth Regul; 1983-1984; 3(4):193-202. PubMed ID: 6241293
[TBL] [Abstract][Full Text] [Related]
20. Subpopulations of human T-lymphocytes. XIX. T-cells and T-cells with receptors for IgMFc (T mu), IgGFc (T gamma), or IgAFc (T alpha) in the peripheral blood and regional lymph nodes of patients with untreated breast cancer.
Gupta S; Cunningham-Rundles S
J Natl Cancer Inst; 1982 Dec; 69(6):1261-4. PubMed ID: 6216359
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
